(R)-3-(1-Aminoethyl)aniline dihydrochloride, 95%, 1g

1-(Piperidin-1-yl)propan-2-ol, 250mg

4-(4-Methylpiperazino)benzonitrile, 95.0%, 10g

Methyl 3-amino-6-bromopicolinate, 95.0%, 1g

1-(4-Bromo-1H-indazol-1-yl)ethanone, 95.0%, 5g

(1-Benzylazetidin-2-yl)methanol, 98+%, 1g

Propylene glycol monobutyl ether, min 99%, for synthesis, 1L, plastic packaging.

9-Hexyl-3,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole>98.0%(HPLC)(N)5g

2-Chloro-5-(4-morpholinyl)benzoic acid, 97%, 250mg

(S)-Methyl 4-(1-aminoethyl)benzoate hydrochloride, 98.0%, 1g

2-Chloronicotinamide, 97.0%, 100g

Triethylene Glycol Mono(2-propynyl) Ether, 96%, 25g

(S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one, 98%, 25mg